Skip to main content
Epocrates Online
Contact us
Explore features
Reach clinicians
Buy now
By
vgreene
, 7 March, 2019
Heart Failure
By
vgreene
, 7 March, 2019
May promote fluid retention, exacerbate heart failure:
By
vgreene
, 7 March, 2019
thiazolidinediones
By
vgreene
, 7 March, 2019
NSAIDs
By
vgreene
, 7 March, 2019
dronedarone (severe or recently decompensated heart failure use)
By
vgreene
, 7 March, 2019
cilostazol
By
vgreene
, 7 March, 2019
non-dihydropyridine (reduced ejection fraction heart failure use)
By
vgreene
, 7 March, 2019
calcium channel blockers
By
vgreene
, 7 March, 2019
Gastric/Duodenal Ulcers
By
vgreene
, 7 March, 2019
May exacerbate existing or produce new/additional ulcers:
Pagination
First page
Previous page
…
Page
2455
Page
2456
Page
2457
Page
2458
Current page
2459
Page
2460
Page
2461
Page
2462
Page
2463
…
Next page
Last page
About Us
Company Overview
Media Relations
Contact
Editorial Policy
Editorial Process
Third-Party Sponsorship Policy
athenahealth
Products
Core Products
Mobile CME
Product Licenses
Business Solutions
Pharma
Market Research
Institutions
Support
Support Center
Install
My Account
Stay Connected
Facebook
Twitter
YouTube